Mexican drug maker Rimsa seeks buyers: Bloomberg

Goldman Sachs is managing the sale of Rimsa, which has attracted interest from companies including Sanofi, Pfizer and Abbott Laboratories.

(Photo: Archive/El Universal)
English 19/09/2015 14:07 Reuters Actualizada 14:07
Guardando favorito...

Privately owned Mexican drug maker Representaciones e Investigaciones Medicas, or Rimsa, is up for sale and could be worth as much as US$1 billion, Bloomberg reported on Friday, citing people familiar with the matter.

Goldman Sachs is managing the sale of Rimsa, which has attracted interest from companies including Sanofi, Pfizer and Abbott Laboratories, the people told Bloomberg.

Rimsa officials could not be reached for comment.

Temas Relacionados
Guardando favorito...
 

Noticias según tus intereses

Comentarios

El Universal

Newsletter Al Despertar

Inicia tu día bien informado con las notas más relevantes

Al registrarme acepto los términos y condiciones